IP Library Granted Patent US 9,346,767
Granted Patent B2
US 9,346,767 · App. 14/734,471 · Granted May 24, 2016

Substituted pyrazines and a process for producing the same

Inventors: Satoshi Inouye (Kanagawa, JP); Yuiko Miura (Kanagawa, JP); Suguru Yoshida (Tokyo, JP); Takamitsu Hosoya (Tokyo, JP)
Assignees: JNC CORPORATION; NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
C07D241/38C07D241/20C07D241/44C07D241/54C07D487/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,346,767
App. No.
14/734,471
Granted
May 24, 2016
Kind
B2
Abstract

Described include (1) a substituted pyrazine compound of general formula (VIII): and (2) a process for producing the substituted pyrazine compound of general formula (VIII), where R 1 is hydrogen, a halogen, a substituted or unsubstituted hydrocarbon group, or a substituted or unsubstituted heterocyclic group, and R 4 is a protecting group. The process comprises (1) the step of reacting 2-amino-3,5-dibromo-6-chloropyrazine with R 1 MgX and ZnCl 2 in the presence of a palladium catalyst to produce a compound of general formula (V); (2) the step of reacting the compound of general formula (V) with a compound of general formula (VI) to produce a compound of general formula (VII); and (3) the step of reacting the compound of formula (VII) with tributyl(vinyl)tin in the presence or a palladium catalyst to given the compound of general formula (VIII).

Claims (18)

1. A compound represented by formula (VIII):

wherein

R 1 is hydrogen; a halogen; an aryl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an arylalkyl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an arylalkenyl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an alkyl which may optionally be substituted with an alicyclic group; an alkenyl which may optionally be substituted with an alicyclic group; an alicyclic group; a heterocyclic group; or an alkynyl which may optionally be substituted with an alicyclic group, and

R 4 is a protecting group selected from the group consisting of methyl, methoxymethyl, tetrahydropyranyl, benzyl, 4-methoxybenzyl, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, phenyldimethylsilyl, tert-butyldiphenylsilyl, and triisopropylsilyl.

2. The compound according to claim 1 , wherein the compound is:

3. A process for producing a compound represented by formula (VIII):

wherein R 1 is hydrogen; a halogen; an aryl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an arylalkyl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an arylalkenyl which may optionally be substituted with at least one substituent selected from the group consisting of a halogen, hydroxy, an alkyl having 1 to 6 carbon atoms, an alkoxy having 1 to 6 carbon atoms, an amino and a dialkylamino having 1 to 6 carbon atoms; an alkyl which may optionally be substituted with an alicyclic group; an alkenyl which may optionally be substituted with an alicyclic group; an alicyclic group; a heterocyclic group; or an alkynyl which may optionally be substituted with an alicyclic group, and

R 4 is a protecting group selected from the group consisting of methyl, methoxymethyl, tetrahydropyranyl, benzyl, 4-methoxybenzyl, tert-butyldimethylsilyl, trimethylsilyl, triethylsilyl, phenyldimethylsilyl, tert-butyldiphenylsilyl, and triisopropylsilyl,

which comprises:

(1) reacting 2-amino-3,5-dibromo-6-chloropyrazine with R 1 MgX and ZnCl 2 , wherein R 1 is the same as defined above and X is a halogen, in the presence of a palladium catalyst to give a compound represented by formula (V):

 wherein R 1 is the same as defined above;

(2) reacting the compound represented by formula (V) with a compound represented by formula (VI):

 wherein R 4 is the same as defined above, in the presence of a palladium catalyst and a base to give a compound represented by formula (VII):

 wherein R 1 and R 4 are the same as defined above; and,

(3) reacting the compound represented by formula (VII) with tributyl(vinyl)tin in the presence of a palladium catalyst to give the compound represented by formula (VIII).

4. The process according to claim 3 , wherein R 1 is selected from the group consisting of phenyl, p-hydroxyphenyl, benzyl, α-hydroxybenzyl, phenylethyl, phenylvinyl, cyclohexyl, cyclohexylmethyl, cyclohexylethyl, methyl, ethyl, propyl, 2-methylpropyl, 2-methylpropenyl, adamantylmethyl, cyclopentylmethyl, and thiophen-2-yl.

5. The process according to claim 3 , wherein R 1 is benzyl.

6. The process according to claim 3 , wherein R 4 is methyl.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2017
From: NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
To: JNC CORPORATION
Reel/Frame 041553/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: INOUYE, SATOSHI; MIURA, YUIKO; YOSHIDA, SUGURU; HOSOYA, TAKAMITSU
To: JNC CORPORATION; NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY
Reel/Frame 041519/0805 →
Priority Claims (1)
JP 2011-050487 · Mar 8, 2011 · national
Continuity (4)
Continuation 14592568 · Jan 8, 2015
Division 14189706 · Feb 25, 2014
Division 13412682 · Mar 6, 2012
Related Publication 20150266833A1 · Sep 24, 2015